Modulight Corp is a biomedical company that designs and manufactures laser devices for the treatment of cancer and eye diseases and for genetics. The company also manufactures products for other high value-add applications such as quantum computing.
2000
70
LTM Revenue $5.5M
LTM EBITDA -$4.9M
$43.7M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Modulight has a last 12-month revenue of $5.5M and a last 12-month EBITDA of -$4.9M.
In the most recent fiscal year, Modulight achieved revenue of $4.4M and an EBITDA of -$3.1M.
Modulight expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Modulight valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $4.3M | $4.4M | XXX | XXX | XXX |
Gross Profit | $6.7M | $5.4M | XXX | XXX | XXX |
Gross Margin | 156% | 122% | XXX | XXX | XXX |
EBITDA | -$8.7M | -$3.1M | XXX | XXX | XXX |
EBITDA Margin | -202% | -69% | XXX | XXX | XXX |
Net Profit | -$9.2M | -$12.7M | XXX | XXX | XXX |
Net Margin | -212% | -290% | XXX | XXX | XXX |
Net Debt | $7.2M | $6.6M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Modulight's stock price is EUR 1 (or $1).
Modulight has current market cap of EUR 53.5M (or $57.5M), and EV of EUR 40.7M (or $43.7M).
See Modulight trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$43.7M | $57.5M | XXX | XXX | XXX | XXX | $-0.18 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Modulight has market cap of $57.5M and EV of $43.7M.
Modulight's trades at 7.9x LTM EV/Revenue multiple, and -8.8x LTM EBITDA.
Analysts estimate Modulight's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Modulight and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $43.7M | XXX | XXX | XXX |
EV/Revenue | 9.9x | XXX | XXX | XXX |
EV/EBITDA | -14.3x | XXX | XXX | XXX |
P/E | -8.3x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | -7.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpModulight's NTM/LTM revenue growth is 75%
Modulight's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Modulight's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Modulight's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Modulight and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 2% | XXX | XXX | XXX | XXX |
EBITDA Margin | -69% | XXX | XXX | XXX | XXX |
EBITDA Growth | -65% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 5% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 349% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Modulight acquired XXX companies to date.
Last acquisition by Modulight was XXXXXXXX, XXXXX XXXXX XXXXXX . Modulight acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Modulight founded? | Modulight was founded in 2000. |
Where is Modulight headquartered? | Modulight is headquartered in Finland. |
How many employees does Modulight have? | As of today, Modulight has 70 employees. |
Who is the CEO of Modulight? | Modulight's CEO is Mr. Seppo Orsila. |
Is Modulight publicy listed? | Yes, Modulight is a public company listed on HEL. |
What is the stock symbol of Modulight? | Modulight trades under MODU ticker. |
When did Modulight go public? | Modulight went public in 2021. |
Who are competitors of Modulight? | Similar companies to Modulight include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of Modulight? | Modulight's current market cap is $57.5M |
What is the current revenue of Modulight? | Modulight's last 12-month revenue is $5.5M. |
What is the current EBITDA of Modulight? | Modulight's last 12-month EBITDA is -$4.9M. |
What is the current EV/Revenue multiple of Modulight? | Current revenue multiple of Modulight is 7.9x. |
What is the current EV/EBITDA multiple of Modulight? | Current EBITDA multiple of Modulight is -8.8x. |
What is the current revenue growth of Modulight? | Modulight revenue growth between 2023 and 2024 was 2%. |
Is Modulight profitable? | Yes, Modulight is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.